Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predictive Value of Enucleation Ratio for Symptomatic Improvement After HoLEP: A Multicenter Prospective Cohort Study

NCT07591688 is registered in ClinicalTrials.gov with Ondokuz Mayıs University as lead sponsor.

NCT NCT07591688
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07591688 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predictive Value of Enucleation Ratio for Symptomatic Improvement After HoLEP: A Multicenter Prospective Cohort Study
Lead sponsor
Ondokuz Mayıs University
Phase
Observational
Overall status
Not yet recruiting
Start date
July 1, 2026
Completion date
March 30, 2027
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostate obstruction (bpo)